These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2115643)

  • 1. Integrity of FOS B leucine zipper is essential for its interaction with JUN proteins.
    Ryseck RP; Kovary K; Bravo R
    Oncogene; 1990 Jul; 5(7):1091-3. PubMed ID: 2115643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. fos and jun interaction: the role of the leucine zipper.
    Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
    Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.
    Sassone-Corsi P; Ransone LJ; Lamph WW; Verma IM
    Nature; 1988 Dec; 336(6200):692-5. PubMed ID: 3143919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly.
    Abate C; Luk D; Curran T
    Cell Growth Differ; 1990 Oct; 1(10):455-62. PubMed ID: 2126189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.
    Macgregor PF; Abate C; Curran T
    Oncogene; 1990 Apr; 5(4):451-8. PubMed ID: 2139203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex.
    Neuberg M; Schuermann M; Hunter JB; Müller R
    Nature; 1989 Apr; 338(6216):589-90. PubMed ID: 2494459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both Jun and Fos contribute to transcription activation by the heterodimer.
    Hirai S; Bourachot B; Yaniv M
    Oncogene; 1990 Jan; 5(1):39-46. PubMed ID: 2108402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.
    Ryseck RP; Bravo R
    Oncogene; 1991 Apr; 6(4):533-42. PubMed ID: 1827665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse vimentin: structural relationship to fos, jun, CREB and tpr.
    Capetanaki Y; Kuisk I; Rothblum K; Starnes S
    Oncogene; 1990 May; 5(5):645-55. PubMed ID: 2140597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered protein conformation on DNA binding by Fos and Jun.
    Patel L; Abate C; Curran T
    Nature; 1990 Oct; 347(6293):572-5. PubMed ID: 2120592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.